After full adjustment, individuals with intact PTH levels >300 pg/mL exhibited a 4.74-fold increased odds ratio (95% CI = 1.53–14.70) for sarcopenia, compared to the reference group with intact PTH levels <150 pg/mL. The gene discussed is PTH; the disease is sarcopenia.